On these pages you can check out the latest breast cancer news from BCAC and our member groups. We also provide up-to-date information and links to current breast cancer research and clinical trials. Read latest stories below, or use the filters or the pager below for other stories. Use the form to the right of this to subscribe to our e-News.
New research from two studies has found postmenopausal patients with early stage breast cancer who take two types of drugs, aromatase inhibitors (such as Letrozole or Anastrozole) together with bisphosphonates, have better survival rates than those who don’t.
Results from the two studies were collated by the Early Breast Cancer Trialists’ Collaborative Group (EBCTCG) group in the UK and published recently in The Lancet medical journal.
The latest innovation in fighting cancer has come to New Zealand and will be trialled in breast cancer patients from this month.
Immunotherapy, which is being used successfully to treat patients with melanoma, will now be trialled in patients with Triple Negative Breast Cancer (TNBC), a rare and aggressive form of breast cancer.
An Auckland woman has considered selling her house to try and pay for the breast cancer medicine, Kadcyla, that will keep her alive. The same breast cancer medicine would be available free through the public health system if she lived in Australia.
“We have looked into selling and moving to the outer suburbs but it’s still very expensive. My husband is still working so we can’t leave Auckland,” says Jyoti (Jo) Bhagat.
Breast Cancer Aotearoa Coalition (BCAC) welcomes news of the government’s new national cancer information strategy which is set to improve access to cancer information nationwide.
BCAC met with the Ministry of Health’s Cancer Team earlier this month for an update on issues raised in our Ministerial Briefing in March. We were pleased to hear that good progress has been made in breast reconstruction and the provision of fertility services. However, we remain concerned about inadequate funding for new medicines and inconsistencies among DHBs in offering lymphoedema services.
Tracey Eising knows that the medicine she is taking to stop her cancer spreading will soon stop working. The only medicine left with a chance of extending her life is Kadcyla, a drug that is currently unfunded in New Zealand. At a cost of $100,000 per year of treatment, Tracey, like most New Zealanders cannot afford it.
A young woman's story of juggling secondary breast cancer with raising five young children on a West Coast farm.
Tamara Malone was 33 years old and pregnant with her third child when fate dealt her a double blow. In December 2009, she was not only told she had HER2+ breast cancer but that she would have to terminate her pregnancy.
A Christchurch teacher is urging women to get regular mammograms after an aggressive breast cancer was picked up during her routine scan just prior to the February 2011 earthquake.
Hannelie Bergmann, 56, is speaking out in support of the Breast Cancer Aotearoa Coalition’s (BCAC) 2014 Show Your Heart for Women Living with Breast Cancer fundraising campaign.